- Home
- PENG vs CDMO Comparison
PENG vs CDMO Comparison
Compare PENG & CDMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PENG
- CDMO
- Stock Information
- Founded
- PENG 1988
- CDMO 1981
- Country
- PENG Cayman Islands
- CDMO United States
- Employees
- PENG N/A
- CDMO N/A
- Industry
- PENG Semiconductors
- CDMO Biotechnology: Pharmaceutical Preparations
- Sector
- PENG Technology
- CDMO Health Care
- Exchange
- PENG Nasdaq
- CDMO Nasdaq
- Market Cap
- PENG 830.2M
- CDMO 793.8M
- IPO Year
- PENG 2017
- CDMO N/A
- Fundamental
- Price
- PENG $20.11
- CDMO $12.50
- Analyst Decision
- PENG Strong Buy
- CDMO Hold
- Analyst Count
- PENG 7
- CDMO 3
- Target Price
- PENG $25.43
- CDMO $12.25
- AVG Volume (30 Days)
- PENG 1.0M
- CDMO 1.3M
- Earning Date
- PENG 01-08-2025
- CDMO 12-10-2024
- Dividend Yield
- PENG N/A
- CDMO N/A
- EPS Growth
- PENG N/A
- CDMO N/A
- EPS
- PENG N/A
- CDMO N/A
- Revenue
- PENG $1,237,651,000.00
- CDMO $150,445,000.00
- Revenue This Year
- PENG $18.38
- CDMO $19.04
- Revenue Next Year
- PENG $10.03
- CDMO $20.87
- P/E Ratio
- PENG N/A
- CDMO N/A
- Revenue Growth
- PENG N/A
- CDMO 6.75
- 52 Week Low
- PENG $14.87
- CDMO $5.90
- 52 Week High
- PENG $29.81
- CDMO $12.51
- Technical
- Relative Strength Index (RSI)
- PENG N/A
- CDMO 65.47
- Support Level
- PENG N/A
- CDMO $12.41
- Resistance Level
- PENG N/A
- CDMO $12.50
- Average True Range (ATR)
- PENG 0.00
- CDMO 0.04
- MACD
- PENG 0.00
- CDMO -0.01
- Stochastic Oscillator
- PENG 0.00
- CDMO 84.62
About CDMO Avid Bioservices Inc.
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.